• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中鼻甲手术的疗效和安全性:系统评价。

Efficacy and safety of middle turbinate surgery: a systematic review.

机构信息

Department of Otolaryngology and Head and Neck Surgery, Istituto Clinico Città Studi, Via Jommelli 17, Milano, 20131, Italy.

Department of Clinical Sciences and Community Health, San Giuseppe Hospital, Università Degli Studi di Milano, Milan, Italy.

出版信息

Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6187-6199. doi: 10.1007/s00405-024-08825-4. Epub 2024 Jul 11.

DOI:10.1007/s00405-024-08825-4
PMID:38992192
Abstract

PURPOSE

Middle turbinate (MT) surgery is extremely common during endoscopic sinus surgery procedures, though no agreement exists on which techniques provide the best outcomes. This PRISMA-compliant systematic review aims to assess which MT surgery technique yields the least postoperative adverse effects and the best objective and subjective outcomes.

METHODS

A comprehensive search criteria was conducted in multiple databases up to July 3, 2023, to identify studies reporting surgical treatments of the MT. After screening and quality assessment, 14 articles were included for analysis. Data on patients demographics, surgical approaches, postoperative treatment and follow-up, objective and subjective outcomes were extracted and reviewed.

RESULTS

Out of 173 unique papers identified, 14 articles met the inclusion criteria, predominantly randomized controlled trials (n = 9). Antero-inferior middle turbinectomy was the predominant surgical approach. Most studies evaluated results with postoperative endoscopy, a superior outcome was documented in the intervention group (ten out of eleven cases). In four out five studies using the SNOT-22, the treatment group was associated with a statistically significant improvement. Olfactory questionnaires highlighted superior olfactory outcome in two out of three studies. The UPSIT score revealed no significant difference between groups. Objective olfactory assessments favored treatment groups in both studies utilizing olfactometry.

CONCLUSIONS

It seems that a partial MT surgical approach consistently yields subjective and objective improvements compared to conservative measures, also suggesting a positive impact on smell function. Despite it appears that better outcomes with fewer complications are consistently achieved with partial techniques, it remains challenging identifying which partial technique surpasses the others, due to significant heterogeneity among the studies.

摘要

目的

中鼻甲(MT)手术在鼻内镜鼻窦手术中非常常见,但哪种技术能提供最佳效果尚无共识。本 PRISMA 符合的系统评价旨在评估哪种 MT 手术技术术后不良反应最少,客观和主观效果最好。

方法

我们在多个数据库中进行了全面的搜索,截止到 2023 年 7 月 3 日,以确定报告 MT 手术治疗的研究。经过筛选和质量评估,纳入了 14 篇文章进行分析。提取并回顾了有关患者人口统计学、手术方法、术后治疗和随访、客观和主观结果的数据。

结果

在 173 篇独特的论文中,有 14 篇文章符合纳入标准,主要为随机对照试验(n=9)。前下鼻甲切除术是主要的手术方法。大多数研究都用术后内镜评估结果,干预组记录到更好的结果(11 例中有 10 例)。在使用 SNOT-22 的四项研究中,治疗组与统计学上显著的改善相关。嗅觉问卷在三项研究中有两项表明治疗组嗅觉结果更好。UPSIT 评分显示两组之间无显著差异。在两项使用嗅觉计的研究中,客观嗅觉评估均支持治疗组。

结论

与保守治疗相比,部分 MT 手术方法似乎能持续带来主观和客观的改善,也提示对嗅觉功能有积极影响。尽管部分技术似乎能获得更好的效果和更少的并发症,但由于研究之间存在显著的异质性,仍难以确定哪种部分技术优于其他技术。

相似文献

1
Efficacy and safety of middle turbinate surgery: a systematic review.中鼻甲手术的疗效和安全性:系统评价。
Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6187-6199. doi: 10.1007/s00405-024-08825-4. Epub 2024 Jul 11.
2
Nasal decongestants in monotherapy for the common cold.用于普通感冒单一疗法的鼻减充血剂。
Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD009612. doi: 10.1002/14651858.CD009612.pub2.
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多患者,在进行子宫内膜破坏术前使用的术前子宫内膜减薄剂。
Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Systemic and topical antibiotics for chronic rhinosinusitis.用于慢性鼻-鼻窦炎的全身及局部用抗生素
Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011994. doi: 10.1002/14651858.CD011994.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Evaluation of the effect of endoscopic partial middleturbinectomy surgery on the quality of life of patients with chronic rhinosinusitis and nasal polyps.评价内镜下中鼻甲部分切除术对慢性鼻-鼻窦炎伴鼻息肉患者生活质量的影响。
Rhinology. 2020 Jun 1;58(3):208-212. doi: 10.4193/Rhin19.258.
2
Comparison of functional endonasal sinus surgery with and without partial middle turbinate resection.
Ann Otol Rhinol Laryngol. 2000 Jul;109(7):634-40. doi: 10.1177/000348940010900704.
3
Middle turbinate resection: issues and controversies.中鼻甲切除术:问题与争议
Am J Rhinol. 2000 May-Jun;14(3):193-7. doi: 10.2500/105065800782102726.